Status:
COMPLETED
Surfactant Disorders and Chronic Lung Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Chronic Lung Disease
Eligibility:
All Genders
1-17 years
Brief Summary
Interstitial lung diseases (ILD) in children represent a heterogeneous group of rare and not well defined disorders. Genetic abnormalities of surfactant proteins B (SFTPB) and more recently C (SFTPC) ...
Detailed Description
The first stage of this project will be to constitute a clinical, radiological, biological database of children (1 moth-17 years) with severe respiratory distress and/or an unexplained chronic ILD. Mu...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Children from 1 month to 17 years old with radiological alveola-interstitial syndrome and:
- Oxygen weaning failure \> 1 month in term newborn babies(\>37th week of PCA)or\> 40 weeks of PCA in preterm babies
- or
- Chronic respiratory disease define by chronic hypoxia and/or clinical signs of respiratory distress (cough, retractions, crackle)
- Exclusion criteria:
- informed consent denied
- absence of social security
Exclusion
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT00783978
Start Date
September 1 2009
End Date
June 1 2012
Last Update
November 19 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Trousseau
Paris, France, 75012